Esomeprazole 40 mg
Esomeprazole 40 mg is a pharmaceutical drug with 11 clinical trials. Currently 1 active trials ongoing. Historical success rate of 90.0%.
Success Metrics
Based on 9 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
1
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
90.0%
9 of 10 finished
10.0%
1 ended early
1
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Esomeprazole and Radiation Induced Esophagitis
Study to Evaluate Effects of Food or Proton Pump Inhibitor on the Pharmacokinetics of Itraconazole in Healthy Volunteers
Study to Evaluate the Influence of Tegoprazan on the Pharmacokinetics of Proguanil in Healthy Volunteers
Esomeprazole or Pantoprazole in Renal Transplantation
Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy
Clinical Trials (11)
Esomeprazole and Radiation Induced Esophagitis
Study to Evaluate Effects of Food or Proton Pump Inhibitor on the Pharmacokinetics of Itraconazole in Healthy Volunteers
Study to Evaluate the Influence of Tegoprazan on the Pharmacokinetics of Proguanil in Healthy Volunteers
Esomeprazole or Pantoprazole in Renal Transplantation
Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy
Comparison of Esomeprazole and Famotidine for Stress Ulcer Prophylaxis in Neurosurgical Intensive Care Unit
To Assess the Efficacy of Esomeprazole 40 mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole
A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)
Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on Low Dose Acetylsalicylic Acid (LDA)
Gastroesophageal Reflux Disease (GERD)/Nighttime Heartburn and Driving Performance
vMII for Measurement of Oesophageal Bolus Transport and Reflux
All 11 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 11